Nanjing, China: The Dimethylacetamide (DMAc) market in China is currently stable but at a lower price point, reflecting bearish market sentiments. This bearishness is primarily driven by a reduction in production costs, which has resulted from declining prices of key feedstocks, Dimethyl Amine, and Acetic Acid. Additionally, the market is experiencing weak demand for Dimethylacetamide from major downstream sectors such as Pharmaceuticals and Construction, as these industries are underperforming, further dampening the overall market dynamics for DMAc.
During the week ending on xxth August, the Dimethylacetamide (DMAc) market in China remained stable at a lower price point of USD xxx/MT (FOB-Nanjing). Export orders for Dimethylacetamide were subdued and experienced a decline, influenced by deteriorating external market conditions. Although purchasing activity decreased as well in August, this was largely due to Chinese manufacturers maintaining adequate input stock levels. Additionally, finished goods inventories for Dimethylacetamide...
